18 Stocks Moving in Thursday’s Pre-Market Session
Gainers
TSR, Inc. (NASDAQ: TSRI) rose 40.2% to $12.89 in pre-market trading after the company reported record revenue for its first quarter.
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours:
Fortress-Backed Cyprium’s Formulated Copper Histidinate Shows Efficacy In Rare Pediatric Disease
Fortress Biotech Inc’s (NASDAQ:FBIO) partner company, Cyprium Therapeutics Inc announced results from an efficacy and safety analysis of data integrated from two CUTX-101…
UPDATE: Fortress Biotech Says Overall Survival Significantly Improved In Patients Treated With CUTX-101; Says Rolling Submission Of New Drug Application To FDA Planned To Begin In Q4 2021
Cyprium Therapeutics, Inc. ("Cyprium"), a Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress") partner company, with support from its licensing partner Sentynl Therapeutics, Inc. ("Sentynl"), a
52 Biggest Movers From Yesterday
Gainers
Paltalk, Inc. (NASDAQ: PALT) shares jumped 60.1% to close at $8.39 on Wednesday.
33 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Paltalk, Inc. (NASDAQ: PALT) shares climbed 37% to $7.18.
AstraZeneca Buys Fortress-Biotech Founded Caelum For $500M
AstraZeneca Plc (NASDAQ:AZN) will take complete control of Caelum Biosciences in a deal worth up to $500 million, sharpening its focus on rare-disease…
Benzinga Pro’s Top 5 Stocks To Watch For Wednesday, Sept. 29, 2021: KMX, CEI, MU, FBIO, BA
Today's 5 Stock Ideas:
CarMax (KMX) - The company reports Q2 earnings results tomorrow on Thursday, Sept. 30th.
Camber Energy (CEI) - The most searched ticker on Benzinga Pro over the last 24
The Daily Biotech Pulse: AbbVie’s Migraine Drug OK’d By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 28)